High urgency

Warning Letters | FDA

Detected August 21, 2026 · in Dietary-Supplement Labeling (FDA)

FDA issued warning letters regarding compliance issues related to dietary supplements, including labeling and claims; companies must address these issues promptly.

Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on August 21, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. All dietary supplement brands, contract manufacturers, private-label sellers, and ingredient suppliers. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate action required upon receipt of a warning letter.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

Increased scrutiny on compliance with labeling, structure/function claims, and Good Manufacturing Practices (GMP).

Who it affects

All dietary supplement brands, contract manufacturers, private-label sellers, and ingredient suppliers.

What you must do

Review and rectify any compliance issues highlighted in warning letters to avoid further regulatory action.

Deadline

Immediate action required upon receipt of a warning letter.

Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters

Never miss a change like this again

Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Dietary-Supplement Labeling (FDA)